Elizabeth A. Browning
Elizabeth Browning has a Ph.D. in biomedical engineering and has more than 15 years of experience working in university and commercial research labs and organizations. Elizabeth understands the challenges of protecting intellectual property in a variety of settings including the transition from academia to the marketplace. Elizabeth has particular scientific experience in cardiovascular disease research, cancer research and molecular imaging in general.
Elizabeth has experience in prosecuting patent applications covering medical devices and molecular and cell biology inventions for both university and industry clients. She also performs patentability searches for new invention disclosures.
Her laboratory experience includes working as a technical director of a university preclinical optical imaging core facility supporting over 40 active research groups, including one that was conducting research into novel optical probes targeting lipid metabolism pathways for improved detection of breast cancer. She also has worked as a consultant,managing a team of scientific and business professionals at three national sites developing statistical validation studies of an algorithm-based clinical decision support tool for management of hypercholesterolemia. This work led to an $1 million award in SBIR Phase II funding and she helped to formulate the development of a commercialization plan for a Phase III transition. Her work for a CRO involved cognitive walkthrough usability testing and research for clients in the medical device and pharmaceutical products industries with products ranging from novel catheter designs to inhalers transitioning from prescription to over-the-counter distribution. As a postdoctoral research fellow, Elizabeth worked in the Institute for Environmental Medicine at University of Pennsylvania, where she investigated the role of ischemia-induced Reactive Oxygen Species (ROS) generation in regulating endothelial pro-angiogenic signaling and vascular remodeling. Elizabeth completed her doctoral research in biomedical engineering at the University of Virginia where her work was largely focused on studying the mechanism of cardiovascular disease, and in particular investigating how hemodynamic shear stress induces endothelial signal transduction pathways involved in vascular inflammation, atherogenesis, and vascular remodeling.